Contact Us / Sitemap / Directions / Patients and Visitors / Career Opportunities / 1-866-WINTHROP
pay your hospital bill pay your doctor's bill
Winthrop University Hospital

A Pancreatic cancer study

Summary

This study is for patients with pancreatic cancer that was removed by surgery. The standard chemotherapy for pancreatic cancer is the chemotherapy drug, gemcitabine. Gemcitabine is considered the most active chemotherapy drug for pancreatic cancer. In this study patients will receive either gemcitabine alone or gemcitabine combined with erlotinib (trade name Tarceva). Erlotinb is a pill that may help treat cancers by blocking a gene that is important in cancer growth If after 5 months of chemotherapy your cancer has not grown back you will be randomized again to either the same chemotherapy received in the first 5 months or receive radiation and fluoropyrimidine ( a type of chemotherapy drug that may help radiation be more effective.

Description

The purpose of this study is to compare the effects, good and/or bad, of the drug erlotinib in combination with gemcitabine to gemcitabine alone for patients with pancreatic cancer that was removed by surgery. Patients will be randomized into two groups either gemcitabine alone or gemcitabine plus tarceva.When patients have completed 5 months of chemotherapy they will be randomized again into two groups. One group will receive the same chemotherapy they received in the first 5 months while the other group will get an additional cycle of the same chemotherapy along with radiation therapy and fluoropyrimidine. Radiation will be given once a day, Monday through Friday for 51/2 weeks ( 28 radiation treatments)

Inclusion/exclusion

Patients must have histologic proof of primary head of pancreas cancer. Patients must have had surgery 21-56 days before registration.

Principal Investigator

Alexander Hindenburg, MD

Department

Oncology/Hematology

Email

ahindenburg@winthrop.org

Other Contact

mstanganelli@winthrop.org
Contact Us / Sitemap / Directions / Career Opportunities / Financial Assistance / Policies
1-866-WINTHROP
subscribe
Winthrop-University Hospital
259 First Street | Mineola NY 11501 | 516-663-0333


This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2014 Winthrop-University Hospital. All rights reserved.
Web site by: Long Island Web Design
page-bottom